Tobira Therapeutics adds two to management team
This article was originally published in Scrip
Tobira Therapeutics has appointed Helen Jenkins senior vice-president of programme leadership, and Dr Sean Dalziel vice-president of pharmaceutical development. Ms Jenkins most recently served as a corporate officer at Nuon Therapeutics and Saegis Pharmaceuticals, responsible for development operations, strategic planning and portfolio management. Dr Dalziel was previously Onyx Pharmaceuticals' representative to the FDA on CMC sections for all pipeline programmes.